Zhao Zhujiang, Wang Ling, Song Wei, Cui He, Chen Gang, Qiao Fengchang, Hu Jiaojiao, Zhou Rongping, Fan Hong
Department of Genetics & Developmental Biology, the Medical School of Southeast University and Key Laboratory of Developmental Genes and Human Diseases, Ministry of Education, Southeast University, 2 Sipailou, Xuanwu, Nanjing, 210009, China.
Jiangning Hospital, Nanjing Medical University, 140 Hanzhong Road, Nanjing, 210000, China.
World J Surg Oncol. 2015 Mar 12;13:101. doi: 10.1186/s12957-015-0513-x.
MicroRNAs (miRNAs) play an important role in a tumor-suppressive or oncogenic manner in carcinogenesis. Alteration expression patterns of miRNAs in gastric cancer (GC) are associated with cancer initiation and progression. In the present study, we evaluated miR-29a-3p expression pattern and its function in gastric carcinogenesis.
The expression of miR-29a-3p in GC tissue samples and cell lines was detected by quantitative real-time PCR (qRT-PCR). After transfected with miR-29a-3p mimics or inhibitor, the cell proliferation, cell migration, and invasion ability were assessed by CCK-8 assay, wound healing assay, and Trans-well assay, respectively. The level of CDK2, CDK4, CDK6, and CyclinD1 were determined by qRT-PCR and Western blot.
Compared with the corresponding non-tumor tissues, miR-29a-3p showed a significant down-regulated expression in tumor tissues. In vitro functional assays demonstrated that enforced miR-29a-3p expression inhibited cell proliferation by reducing the expression of CDK2, CDK4, and CDK6. Wound healing and Transwell assays revealed that miR-29a-3p suppressed tumor metastasis in GC.
Our preliminary results suggest that altered expression of miR-29a-3p is involved in gastric cancer process. The present study provides the first insight into the specific role of miR-29a-3p in gastric carcinogenesis.
微小RNA(miRNA)在致癌过程中以肿瘤抑制或致癌的方式发挥重要作用。胃癌(GC)中miRNA表达模式的改变与癌症的发生和发展有关。在本研究中,我们评估了miR-29a-3p在胃癌发生中的表达模式及其功能。
采用定量实时荧光定量PCR(qRT-PCR)检测miR-29a-3p在GC组织样本和细胞系中的表达。转染miR-29a-3p模拟物或抑制剂后,分别通过CCK-8法、伤口愈合实验和Trans-well实验评估细胞增殖、细胞迁移和侵袭能力。通过qRT-PCR和蛋白质免疫印迹法检测CDK2、CDK4、CDK6和细胞周期蛋白D1的水平。
与相应的非肿瘤组织相比,miR-29a-3p在肿瘤组织中表达显著下调。体外功能实验表明,增强miR-29a-3p表达可通过降低CDK2、CDK4和CDK6的表达来抑制细胞增殖。伤口愈合实验和Transwell实验显示,miR-29a-3p抑制GC中的肿瘤转移。
我们的初步结果表明,miR-29a-3p表达改变参与了胃癌的发生过程。本研究首次深入了解了miR-29a-3p在胃癌发生中的具体作用。